Pharmaceutical

Attovia secures $105m to advance development of lead programmes

Attovia Therapeutics has secured $105m in a Series B financing round to expedite the development of its lead programmes.

May 11, 2024 - 04:00
Attovia secures $105m to advance development of lead programmes
Attovia Therapeutics has secured $105m in a Series B financing round to expedite the development of its lead programmes.
Read the original article

Tags:

Previous Article

Four ways the vaccine rush will define infectious disease trends for CROs in 2024

Next Article

Novo Nordisk enters deal to develop obesity therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Former FDA official lays out how to keep patients safe from risky medical devices

STAT+: Former FDA official lays out how to keep patient...

Oct 2, 2023

STAT Virtual Event: The State of Biosimilars: What to Watch

STAT Virtual Event: The State of Biosimilars: What to W...

Jul 18, 2023

Dermavant maps out atopic dermatitis filing after positive Phase III data 

Dermavant maps out atopic dermatitis filing after posit...

Jan 13, 2024